UCB SA (EUR)
UCB
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 74.32 | 75.88 |
| 52-Wk Range | - | - |
| Last Close | 76.12 |
| Mkt Cap (m) | 14,388.62 |
| Dividend yield | 1.67 |
| ISIN | BE0003739530 |
| Volume | 296,211.00 |
| Exchange Venue | BRU |
Company Profile
UCB SA is engaged in the development of novel therapies for the treatment of central nervous system and immunological diseases.
Key Information
| Price/Earning | 10.10 |
| Price/Book | 1.98 |
| Price/Sales | 1.38 |
| P/CF | 6.85 |
| Rev Growth (3 year avg) | 5.68 |
| EPS Growth (3 year avg) | -0.02 |
| Operating Margin % | 20.57 |
| Net Margin % | 13.69 |
| Return on Equity | 10.23 |
| Debt/Equity | 0.38 |
Financials
Income Statement
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Revenue (m) | 3,876.00 | 4,178.00 | 4,530.00 | 4,632.00 | 4,913.00 | 5,347.00 |
| Operating Income (m) | 717.00 | 967.00 | 1,137.00 | 1,163.00 | 1,073.00 | 1,100.00 |
| Net Income (m) | 623.00 | 520.00 | 753.00 | 800.00 | 792.00 | 732.00 |
| Basic EPS | 6.50 | 5.52 | 8.00 | 8.48 | 8.46 | 7.74 |
| Avg. Diluted Shares Outstanding (m) | 96.04 | 94.18 | 94.14 | 94.24 | 93.61 | 97.12 |
Balance Sheet
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Current Assets (m) | 2,838.00 | 2,331.00 | 2,677.00 | 2,950.00 | 3,295.00 | 3,582.00 |
| Non Current Assets (m) | 8,118.00 | 7,881.00 | 7,240.00 | 7,564.00 | 7,785.00 | 9,737.00 |
| Total Assets (m) | 10,956.00 | 10,212.00 | 9,917.00 | 10,514.00 | 11,081.00 | 13,319.00 |
| Current Liabilities (m) | 3,061.00 | 2,418.00 | 1,949.00 | 2,238.00 | 2,394.00 | 2,814.00 |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 5,672.00 | 5,584.00 | 5,813.00 | 6,310.00 | 7,039.00 | 7,271.00 |
Cash Flows
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Operating Cash Flows (m) | 245.00 | 427.00 | 927.00 | 1,089.00 | 882.00 | 1,080.00 |
| Capital Expenditure (m) | -146.00 | -138.00 | -209.00 | -341.00 | -294.00 | -349.00 |
Figures are quoted in EUR unless stated otherwise
-0.24 (-0.32%)
€
75.88
Last Price
© 2021 MeDirect Bank (Malta) plc. All rights reserved.